• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用含金纳米棒的复合膜实现外部控制药物释放。

Externally controlled drug release using a gold nanorod contained composite membrane.

机构信息

Department of Chemistry, Sahmyook University, Seoul, 01795, Korea.

Department of Chemistry, Ulsan National Institute of Science and Technology, Ulsan, 44919, Korea.

出版信息

Nanoscale. 2016 Jun 9;8(23):11949-55. doi: 10.1039/c6nr00362a.

DOI:10.1039/c6nr00362a
PMID:27240476
Abstract

Versatile drug delivery devices using nanoporous membranes consisting of gold nanorods and dendrimers have been demonstrated to provide light-triggered on-demand pulsatile release from a reservoir containing highly enriched therapeutics for a real patient's needs. The drug release rate is directly correlated with the temperature increase and irradiated energy of a near-IR laser in both static and fluidic devices. This biocompatible platform for on-demand control was further confirmed by in vitro experiments. Interestingly, different responses to stimuli were obtained from each drug in the absence and presence of NIR light, indicating the versatile potential of our on-demand drug delivery system in less-invasive therapies requiring multi-drug delivery strategies. The enhanced delivery system will improve therapeutic efficacy and reduce side effects through regulation of plasma drug profiles.

摘要

采用金纳米棒和树枝状大分子组成的多孔膜的多功能药物输送装置已经被证明可以提供按需的光触发脉冲释放,从含有高度浓缩治疗剂的储液器中按需释放,以满足真实患者的需求。药物释放率与静态和流动装置中近红外激光的温度升高和辐照能量直接相关。这种用于按需控制的生物相容性平台通过体外实验得到了进一步证实。有趣的是,在没有和存在近红外光的情况下,每种药物对刺激的反应都不同,这表明我们的按需药物输送系统在需要多药物输送策略的微创治疗中具有多功能潜力。通过调节血浆药物谱,增强的输送系统将提高治疗效果并减少副作用。

相似文献

1
Externally controlled drug release using a gold nanorod contained composite membrane.利用含金纳米棒的复合膜实现外部控制药物释放。
Nanoscale. 2016 Jun 9;8(23):11949-55. doi: 10.1039/c6nr00362a.
2
Near-infrared light triggered release of molecules from supramolecular hydrogel-nanorod composites.近红外光触发超分子水凝胶-纳米棒复合材料中分子的释放。
Nanomedicine (Lond). 2016 Jun;11(12):1579-90. doi: 10.2217/nnm-2016-0070. Epub 2016 May 13.
3
Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect.金纳米簇标记的热敏脂质体通过光热效应增强肿瘤微环境中的触发药物释放。
J Control Release. 2015 Oct 28;216:132-9. doi: 10.1016/j.jconrel.2015.08.002. Epub 2015 Aug 4.
4
Gold Nanorods as Nanodevices for Bioimaging, Photothermal Therapeutics, and Drug Delivery.金纳米棒作为用于生物成像、光热疗法和药物递送的纳米器件。
Chem Pharm Bull (Tokyo). 2017;65(7):625-628. doi: 10.1248/cpb.c17-00102.
5
Design and Near-Infrared Actuation of a Gold Nanorod⁻Polymer Microelectromechanical Device for On-Demand Drug Delivery.用于按需给药的金纳米棒-聚合物微机电装置的设计与近红外驱动
Micromachines (Basel). 2018 Jan 13;9(1):28. doi: 10.3390/mi9010028.
6
Controlled-release system mediated by a retro Diels-Alder reaction induced by the photothermal effect of gold nanorods.金纳米棒光热效应诱导的逆向 Diels-Alder 反应介导的控释体系。
Langmuir. 2011 Dec 6;27(23):14621-6. doi: 10.1021/la2036746. Epub 2011 Oct 28.
7
Dual Wavelength-Triggered Gold Nanorods for Anticancer Treatment.用于抗癌治疗的双波长触发金纳米棒
Methods Mol Biol. 2017;1570:195-208. doi: 10.1007/978-1-4939-6840-4_13.
8
Fabrication of Plasmonic Nanorod-Embedded Dipeptide Microspheres via the Freeze-Quenching Method for Near-Infrared Laser-Triggered Drug-Delivery Applications.通过冷冻猝灭法制备用于近红外激光触发药物递送应用的等离子体纳米棒嵌入二肽微球
Biomacromolecules. 2016 May 9;17(5):1788-94. doi: 10.1021/acs.biomac.6b00214. Epub 2016 Apr 18.
9
Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy.金纳米棒嵌入的还原响应嵌段共聚物胶束触发药物递送联合光热消融用于靶向癌症治疗。
Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3039-3052. doi: 10.1016/j.bbagen.2016.10.004. Epub 2016 Oct 6.
10
On-Demand Drug Delivery System Using Micro-organogels with Gold Nanorods.使用含金纳米棒的微生物凝胶的按需给药系统
ACS Med Chem Lett. 2016 Oct 10;7(12):1087-1091. doi: 10.1021/acsmedchemlett.6b00293. eCollection 2016 Dec 8.

引用本文的文献

1
NIR-Responsive Microbubble Delivery Platforms for Controlled Drug Release in Cancer Therapy.用于癌症治疗中可控药物释放的近红外响应性微泡递送平台
Materials (Basel). 2025 Jun 10;18(12):2725. doi: 10.3390/ma18122725.
2
Hybrid Systems of Gels and Nanoparticles for Cancer Therapy: Advances in Multifunctional Therapeutic Platforms.用于癌症治疗的凝胶与纳米颗粒混合系统:多功能治疗平台的进展
Gels. 2025 Feb 26;11(3):170. doi: 10.3390/gels11030170.
3
Applications of Nanoporous Gold in Therapy, Drug Delivery, and Diagnostics.纳米多孔金在治疗、药物递送和诊断中的应用。
Metals (Basel). 2023 Jan;13(1). doi: 10.3390/met13010078. Epub 2022 Dec 28.
4
Gold nanorod-based smart platform for efficient cellular uptake and combination therapy.基于金纳米棒的智能平台用于高效细胞摄取和联合治疗。
RSC Adv. 2024 Aug 28;14(37):27385-27393. doi: 10.1039/d4ra06051b. eCollection 2024 Aug 22.
5
Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy.功能化肽在用于有效癌症治疗的纳米医学中的作用。
Biomedicines. 2024 Jan 16;12(1):202. doi: 10.3390/biomedicines12010202.
6
On-Demand Drug Delivery Systems Using Nanofibers.基于纳米纤维的按需给药系统
Nanomaterials (Basel). 2021 Dec 16;11(12):3411. doi: 10.3390/nano11123411.
7
Stimuli-Responsive Nanofibers Containing Gold Nanorods for On-Demand Drug Delivery Platforms.用于按需给药平台的含金纳米棒的刺激响应性纳米纤维
Pharmaceutics. 2021 Aug 23;13(8):1319. doi: 10.3390/pharmaceutics13081319.
8
Nanomaterials for Biomedical Applications: Production, Characterisations, Recent Trends and Difficulties.用于生物医学应用的纳米材料:生产、特性、最新趋势和难点。
Molecules. 2021 Feb 18;26(4):1077. doi: 10.3390/molecules26041077.
9
Development of Gold Nanoparticle Micropatterns for the Electrical Detection of Proteins.用于蛋白质电学检测的金纳米颗粒微图案的开发。
Nanomaterials (Basel). 2021 Feb 19;11(2):528. doi: 10.3390/nano11020528.
10
Silicon Nanofluidic Membrane for Electrostatic Control of Drugs and Analytes Elution.用于药物和分析物洗脱静电控制的硅纳米流体膜
Pharmaceutics. 2020 Jul 19;12(7):679. doi: 10.3390/pharmaceutics12070679.